Elutia (ELUT) Cash from Investing Activities Growth (1y) (2020 - 2026)
Elutia (ELUT) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -208.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -397.90% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -514.25% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -187.82% |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn | 87.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.77% |
| Dec 31, 2025 | 84,760.64% |
| Sep 30, 2025 | -15.17% |
| Jun 30, 2025 | -162.64% |
| Mar 31, 2025 | -1,753.33% |
| Dec 31, 2024 | -100.65% |
| Sep 30, 2024 | -782.26% |
| Jun 30, 2024 | 314.12% |
| Mar 31, 2024 | 91.76% |
| Dec 31, 2023 | 10,948.51% |
| Sep 30, 2023 | 47.01% |
| Jun 30, 2023 | 66.67% |
| Mar 31, 2023 | -435.29% |
| Dec 31, 2022 | -436.00% |
| Sep 30, 2022 | -20.62% |
| Jun 30, 2022 | -119.83% |
| Mar 31, 2022 | 74.05% |
| Dec 31, 2021 | 78.26% |
| Sep 30, 2021 | 77.75% |
| Jun 30, 2021 | -329.63% |